Literature DB >> 7489940

Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group.

T Schneider1, H U Jahn, W Schmidt, E O Riecken, M Zeitz, R Ullrich.   

Abstract

Although changes in T lymphocyte subset distribution in the peripheral blood of patients infected with human immunodeficiency virus (HIV) are well defined it is not known whether these changes reflect changes in lymphoid compartments clearly involved in HIV related disease like the intestinal mucosa. This study analysed lymphocytes isolated simultaneously from the peripheral blood and duodenal biopsy specimens by three colour flow cytometry in eight asymptomatic HIV infected patients, 26 AIDS patients, and 23 controls. The proportion of CD4, CD8, CD4-CD8-, or gamma delta T cells did not correlate between circulating and duodenal T cells. CD4 T cells were reduced in the peripheral blood (7.5% (25th-75th percentile, 2-16%) v 52% (41-63%), p < 0.0005) and even more reduced in the duodenum (1% (1-2%) v 36% (23-57%), p < 0.0005) of AIDS patients compared with controls. Patients with asymptomatic HIV infection had intermediate CD4 T cells in the peripheral blood (24% (22-35%); p < 0.002 v controls; p < 0.01 v AIDS) but like AIDS patients very low CD4 T cells in the duodenum (3% (1-6%); p < 0.002 v controls). The ratio of duodenal to circulating CD4+ T cells was significantly reduced to 0.2 (0-1) in AIDS patients (p < 0.001) and even to 0.1 (0.04-0.5) in asymptomatic HIV infected patients (p < 0.002) compared with 0.72 (0.44-0.95) in controls. These findings show an early and preferential loss of duodenal CD4 T cells in HIV infection. Immunological abnormalities in HIV infection are distinct between lymphoid compartments, and profound immunodeficiency may occur in the intestinal immune system although circulating T cells are largely preserved.

Entities:  

Mesh:

Year:  1995        PMID: 7489940      PMCID: PMC1382905          DOI: 10.1136/gut.37.4.524

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  T cell differentiation antigens on lymphocytes in the human intestinal lamina propria.

Authors:  H L Schieferdecker; R Ullrich; H Hirseland; M Zeitz
Journal:  J Immunol       Date:  1992-10-15       Impact factor: 5.422

2.  Expression of nef, vpu, CA and CD4 during the infection of lymphoid and monocytic cell lines with HIV-1.

Authors:  T Schneider; P Hildebrandt; K Rokos; U Schubert; W Rönspeck; C Grund; A Beck; R Blesken; G Kulins; H Oldenburg
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Mucosal T cells provide helper function but do not proliferate when stimulated by specific antigen in lymphogranuloma venereum proctitis in nonhuman primates.

Authors:  M Zeitz; T C Quinn; A S Graeff; S P James
Journal:  Gastroenterology       Date:  1988-02       Impact factor: 22.682

4.  Loss of mucosal CD4 lymphocytes is an early feature of HIV infection.

Authors:  S G Lim; A Condez; C A Lee; M A Johnson; C Elia; L W Poulter
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

5.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

6.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.

Authors:  J Embretson; M Zupancic; J L Ribas; A Burke; P Racz; K Tenner-Racz; A T Haase
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

7.  Abnormalities in intestinal mucosal T cells in homosexual populations including those with the lymphadenopathy syndrome and acquired immunodeficiency syndrome.

Authors:  V D Rodgers; R Fassett; M F Kagnoff
Journal:  Gastroenterology       Date:  1986-03       Impact factor: 22.682

8.  Duodenal mucosal T cell subpopulation and bacterial cultures in acquired immune deficiency syndrome.

Authors:  M Budhraja; H Levendoglu; F Kocka; M Mangkornkanok; R Sherer
Journal:  Am J Gastroenterol       Date:  1987-05       Impact factor: 10.864

9.  Analysis of intestinal lymphocyte subpopulations in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

Authors:  S Ellakany; T L Whiteside; R R Schade; D H van Thiel
Journal:  Am J Clin Pathol       Date:  1987-03       Impact factor: 2.493

10.  Lymphocytes isolated from the intestinal lamina propria of normal nonhuman primates have increased expression of genes associated with T-cell activation.

Authors:  M Zeitz; W C Greene; N J Peffer; S P James
Journal:  Gastroenterology       Date:  1988-03       Impact factor: 22.682

View more
  74 in total

1.  Differential effects of simian immunodeficiency virus infection on immune inductive and effector sites in the rectal mucosa of rhesus macaques.

Authors:  M Vajdy; R S Veazey; H K Knight; A A Lackner; M R Neutra
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  HIV1 and the gut in the era of highly active antiretroviral therapy.

Authors:  Esteban C Nannini; Pablo C Okhuysen
Journal:  Curr Gastroenterol Rep       Date:  2002-10

3.  CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals.

Authors:  C Loiseau; M Requena; M Mavigner; M Cazabat; N Carrere; B Suc; K Barange; L Alric; B Marchou; P Massip; J Izopet; P Delobel
Journal:  Mucosal Immunol       Date:  2016-02-17       Impact factor: 7.313

4.  Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.

Authors:  R S Veazey; I C Tham; K G Mansfield; M DeMaria; A E Forand; D E Shvetz; L V Chalifoux; P K Sehgal; A A Lackner
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 5.  Pathogenesis of HIV in the gastrointestinal tract.

Authors:  Satya Dandekar
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

6.  Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: protection correlates with neutralizing antibody.

Authors:  John B Schell; Kapil Bahl; Nina F Rose; Linda Buonocore; Meredith Hunter; Preston A Marx; Celia C LaBranche; David C Montefiori; John K Rose
Journal:  Vaccine       Date:  2012-04-23       Impact factor: 3.641

Review 7.  Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".

Authors:  Kimberly A Schoenly; David B Weiner
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

Review 8.  HIV infection and the gastrointestinal immune system.

Authors:  J M Brenchley; D C Douek
Journal:  Mucosal Immunol       Date:  2008-01       Impact factor: 7.313

9.  Dendritic cells transmit HIV-1 through human small intestinal mucosa.

Authors:  Ruizhong Shen; Lesley E Smythies; Ronald H Clements; Lea Novak; Phillip D Smith
Journal:  J Leukoc Biol       Date:  2009-12-09       Impact factor: 4.962

10.  Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.

Authors:  Moraima Guadalupe; Elizabeth Reay; Sumathi Sankaran; Thomas Prindiville; Jason Flamm; Andrew McNeil; Satya Dandekar
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.